Skip to Content Skip to Search

Christophe Mulfinger

Site Director Ste. Foy Site - GSK Vaccines

Portrait of Christophe Mulfinger
Christophe Mulfinger

Christophe was appointed to the role of Site Director in October 2020 and is responsible for site operations of the Ste. Foy, Quebec vaccine manufacturing site. He sits on the GSK Canadian Country Executive Board representing GSK vaccines manufacturing.

Prior to taking the role of Site Director in Ste. Foy, he led the external supply team where he managed all contract manufacturing organizations (CMOs) partnerships in order to support manufacturing and supply for GSK’s broad portfolio of vaccines.  Throughout most of his career at GSK, Christophe worked in roles of increasing responsibility within the Vaccines group, notably on the development and manufacturing of the seasonal and pandemic Influenza vaccines.

Christophe studied at the Université libre de Bruxelles (Belgium) where he graduated in bioengineering. He also holds an International Executive MBA from the Louvain School of Management in Belgium.